T1 mapping and cardiac magnetic resonance feature tracking in mitral valve prolapse.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 03 01 2020
accepted: 03 08 2020
revised: 10 06 2020
pubmed: 18 8 2020
medline: 15 4 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

T1 mapping (T1-map) and cardiac magnetic resonance feature tracking (CMR-FT) techniques have been introduced for the early detection of interstitial myocardial fibrosis and deformation abnormalities. We sought to demonstrate that T1-map and CMR-FT may identify the presence of subclinical myocardial structural changes in patients with mitral valve prolapse (MVP). Consecutive MVP patients with moderate-to-severe mitral regurgitation and comparative matched healthy subjects were prospectively enrolled and underwent CMR-FT analysis to calculate 2D global and segmental circumferential (CS) and radial strain (RS) and T1-map to determine global and segmental native T1 (nT1) values. Seventy-three MVP patients (mean age, 57 ± 13 years old; male, 76%; regurgitant volume, 57 ± 21 mL) and 42 matched control subjects (mean age, 56 ± 18 years; male, 74%) were included. MVP patients showed a lower global CS (- 16.3 ± 3.4% vs. - 17.8 ± 1.9%, p = 0.020) and longer global nT1 (1124.9 ± 97.7 ms vs. 1007.4 ± 26.1 ms, p < 0.001) as compared to controls. Moreover, MVP patients showed lower RS and CS in basal (21.6 ± 12.3% vs. 27.6 ± 8.9%, p = 0.008, and - 13.0 ± 6.7% vs. - 14.9 ± 4.1%, p = 0.013) and mid-inferolateral (20.6 ± 10.7% vs. 28.4 ± 8.7%, p < 0.001, and - 12.8 ± 6.3% vs. - 16.5 ± 4.0%, p < 0.001) walls as compared to other myocardial segments. Similarly, MVP patients showed longer nT1 values in basal (1080 ± 68 ms vs. 1043 ± 43 ms, p < 0.001) and mid-inferolateral (1080 ± 77 ms vs. 1034 ± 37 ms, p < 0.001) walls as compared to other myocardial segments. Of note, nT1 values were significantly correlated with CS (r, 0.36; p < 0.001) and RS (r, 0.37; p < 0.001) but not with regurgitant volume. T1-map and CMR-FT identify subclinical left ventricle tissue changes in patients with MVP. Further studies are required to correlate these subclinical tissue changes with the outcome. • T1 mapping (T1-map) and cardiac magnetic resonance feature tracking (CMR-FT) techniques have been introduced for the early detection of interstitial myocardial fibrosis and deformation abnormalities. • In MVP patients, we demonstrated a longer global nT1 with associated reduced global circumferential (CS) and radial strain (RS) as compared to control subjects. • Among MVP patients, the mid-basal left ventricle inferolateral wall showed longer nT1 with reduced CS and RS as compared to other myocardial segments. Further studies are required to correlate these subclinical tissue changes with the outcome.

Identifiants

pubmed: 32803414
doi: 10.1007/s00330-020-07140-w
pii: 10.1007/s00330-020-07140-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1100-1109

Références

Delling FN, Vasan RS (2014) Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation 129:2158–2170
doi: 10.1161/CIRCULATIONAHA.113.006702
Levine RA, Hagege AA, Judge DP et al (2015) Mitral valve disease--morphology and mechanisms. Nat Rev Cardiol 12:689–710
doi: 10.1038/nrcardio.2015.161
Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ (1985) Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients. N Engl J Med 313:1305–1309
doi: 10.1056/NEJM198511213132101
Narayanan K, Uy-Evanado A, Teodorescu C et al (2016) Mitral valve prolapse and sudden cardiac arrest in the community. Heart Rhythm 13:498–503
doi: 10.1016/j.hrthm.2015.09.026
Lancellotti P, Garbi M (2016) Malignant mitral valve prolapse: substrates to ventricular remodeling and arrhythmias. Circ Cardiovasc Imaging 9:e005248
doi: 10.1161/CIRCIMAGING.116.005248
Hourdain J, Clavel MA, Deharo JC et al (2018) Common phenotype in patients with mitral valve prolapse who experienced sudden cardiac death. Circulation 138:1067–1069
doi: 10.1161/CIRCULATIONAHA.118.033488
Hutchins GM, Moore GW, Skoog DK (1986) The association of floppy mitral valve with disjunction of the mitral annulus fibrosus. N Engl J Med 314:535–540
doi: 10.1056/NEJM198602273140902
Basso C, Perazzolo Marra M, Rizzo S et al (2015) Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation 132:556–566
doi: 10.1161/CIRCULATIONAHA.115.016291
Kitkungvan D, Nabi F, Kim RJ et al (2018) Myocardial fibrosis in patients with primary mitral regurgitation with and without prolapse. J Am Coll Cardiol 72:823–834
doi: 10.1016/j.jacc.2018.06.048
Perazzolo Marra M, Basso C, De Lazzari M et al (2016) Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging 9:e005030
doi: 10.1161/CIRCIMAGING.116.005030
Salerno M, Kramer CM (2009) Advances in cardiovascular MRI for diagnostics: applications in coronary artery disease and cardiomyopathies. Expert Opin Med Diagn 3:673–687
doi: 10.1517/17530050903140514
Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75
doi: 10.1186/s12968-017-0389-8
Puntmann VO, D'Cruz D, Smith Z et al (2013) Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus. Circ Cardiovasc Imaging 6:295–301
doi: 10.1161/CIRCIMAGING.112.000151
Schuster A, Hor KN, Kowallick JT, Beerbaum P, Kutty S (2016) Cardiovascular magnetic resonance myocardial feature tracking: concepts and clinical applications. Circ Cardiovasc Imaging 9:e004077
doi: 10.1161/CIRCIMAGING.115.004077
Zerhouni EA, Parish DM, Rogers WJ, Yang A, Shapiro EP (1988) Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion. Radiology 169:59–63
doi: 10.1148/radiology.169.1.3420283
Lancellotti P, Tribouilloy C, Hagendorff A et al (2013) Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14:611–644
doi: 10.1093/ehjci/jet105
Pepi M, Tamborini G, Maltagliati A et al (2006) Head-to-head comparison of two- and three-dimensional transthoracic and transesophageal echocardiography in the localization of mitral valve prolapse. J Am Coll Cardiol 48:2524–2530
doi: 10.1016/j.jacc.2006.02.079
Tamborini G, Muratori M, Maltagliati A et al (2010) Pre-operative transthoracic real-time three-dimensional echocardiography in patients undergoing mitral valve repair: accuracy in cases with simple vs. complex prolapse lesions. Eur J Echocardiogr 11:778–785
doi: 10.1093/ejechocard/jeq066
Carpentier A (1983) Cardiac valve surgery--the "French correction". J Thorac Cardiovasc Surg 86:323–337
doi: 10.1016/S0022-5223(19)39144-5
Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E (2013) Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 15:91
doi: 10.1186/1532-429X-15-91
Uretsky S, Argulian E, Narula J, Wolff SD (2018) Use of cardiac magnetic resonance imaging in assessing mitral regurgitation: current evidence. J Am Coll Cardiol 71:547–563
doi: 10.1016/j.jacc.2017.12.009
Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 18:539–542
pubmed: 12135124
Gripari P, Mapelli M, Bellacosa I et al (2018) Transthoracic echocardiography in patients undergoing mitral valve repair: comparison of new transthoracic 3D techniques to 2D transoesophageal echocardiography in the localization of mitral valve prolapse. Int J Cardiovasc Imaging 34:1099–1107
doi: 10.1007/s10554-018-1324-2
Uretsky S, Gillam L, Lang R et al (2015) Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol 65:1078–1088
doi: 10.1016/j.jacc.2014.12.047
Edwards NC, Moody WE, Yuan M et al (2014) Quantification of left ventricular interstitial fibrosis in asymptomatic chronic primary degenerative mitral regurgitation. Circ Cardiovasc Imaging 7:946–953
doi: 10.1161/CIRCIMAGING.114.002397
Bui AH, Roujol S, Foppa M et al (2017) Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia. Heart 103:204–209
doi: 10.1136/heartjnl-2016-309303
Muscogiuri G, Suranyi P, Schoepf UJ et al (2018) Cardiac magnetic resonance T1-mapping of the myocardium: technical background and clinical relevance. J Thorac Imaging 33:71–80
doi: 10.1097/RTI.0000000000000270
Taylor AJ, Salerno M, Dharmakumar R, Jerosch-Herold M (2016) T1 Mapping: basic techniques and clinical applications. JACC Cardiovasc Imaging 9:67–81
doi: 10.1016/j.jcmg.2015.11.005
Almutairi HM, Boubertakh R, Miquel ME, Petersen SE (2017) Myocardial deformation assessment using cardiovascular magnetic resonance-feature tracking technique. Br J Radiol 90:20170072
doi: 10.1259/bjr.20170072
Peng J, Zhao X, Zhao L et al (2018) Normal values of myocardial deformation assessed by cardiovascular magnetic resonance feature tracking in a healthy Chinese population: a multicenter study. Front Physiol 9:1181
doi: 10.3389/fphys.2018.01181
Miller MA, Dukkipati SR, Turagam M, Liao SL, Adams DH, Reddy VY (2018) Arrhythmic mitral valve prolapse: JACC review topic of the week. J Am Coll Cardiol 72:2904–2914
doi: 10.1016/j.jacc.2018.09.048
Nakamori S, Dohi K, Ishida M et al (2018) Native T1 mapping and extracellular volume mapping for the assessment of diffuse myocardial fibrosis in dilated cardiomyopathy. JACC Cardiovasc Imaging 11:48–59
doi: 10.1016/j.jcmg.2017.04.006

Auteurs

Marco Guglielmo (M)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Laura Fusini (L)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Giuseppe Muscogiuri (G)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Francesca Baessato (F)

Divisione di Cardiologia, Dipartimento di Medicina, Università degli Studi, Verona, Italy.

Antonella Loffreno (A)

U.O.C. Cardiologia 1, Ospedale di Circolo e Fondazione Macchi, Università degli Studi, Varese, Italy.

Annachiara Cavaliere (A)

Dipartimento di Medicina, Istituto di Radiologia, Università degli Studi, Padua, Italy.

Giulia Rizzon (G)

Dipartimento di Medicina, Istituto di Radiologia, Università degli Studi, Padua, Italy.

Andrea Baggiano (A)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Mark G Rabbat (MG)

Loyola University of Chicago, Chicago, IL, USA.
Edward Hines Jr. VA Hospital, Hines, IL, USA.

Manuela Muratori (M)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Gloria Tamborini (G)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Ludovica M L Danza (LML)

Division of Cardiology, University of Rome Tor Vergata, Rome, Italy.

Alberico Del Torto (A)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.
Department of Cardiovascular Sciences and Community Health, University of Milan, Milan, Italy.

Elisabetta Tonet (E)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, FE, Italy.

Giacomo Viani (G)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.
Department of Cardiovascular Sciences and Community Health, University of Milan, Milan, Italy.

Saima Mushtaq (S)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Edoardo Conte (E)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Giorgia Bonalumi (G)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Paola Gripari (P)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Marco Zanobini (M)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Daniele Andreini (D)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.
Department of Cardiovascular Sciences and Community Health, University of Milan, Milan, Italy.

Francesco Alamanni (F)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.
Department of Cardiovascular Sciences and Community Health, University of Milan, Milan, Italy.

Mauro Pepi (M)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy.

Andrea I Guaricci (AI)

Institute of Cardiovascular Disease, Department of Emergency and Organ Transplantation, University Hospital Policlinico of Bari, Bari, Italy.

Gianluca Pontone (G)

Centro Cardiologico Monzino IRCCS, Department of Cardiovascular Imaging, Via C. Parea 4, 20138, Milan, Italy. gianluca.pontone@ccfm.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH